Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin vs Tamsulosin in BPH
NCT07467343Phase 4Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Mar 2026
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of silodosin in benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) (2 arms), sponsored by Ain Shams University. Primary endpoint: International Prostate Symptom Score at Week 8. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
silodosin
03
Conditions
benign prostatic hyperplasia (BPH)lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT07467343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07467343.